Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell Therapy

Published:2022-07 Issue:7 Volume:97 Page:1294-1304
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Farooqui Naba^ORCID,Sy-Go Janina Paula T.,Miao Jing,Mehta Ramila,Vaughan Lisa E.,Bennani N. Nora,Wang Yucai,Bansal Radhika,Hathcock Matthew A.,Hayman Suzanne R.,Johnston Patrick B.,Villasboas Jose C.,Paludo Jonas^ORCID,Ansell Stephen M.,Leung Nelson,Lin Yi,Herrmann Sandra M.^ORCID

Funder

NIDDK Division of Diabetes Endocrinology and Metabolic Diseases

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Mayo Clinic

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Biology and clinical application of CAR T cells for B cell malignancies;Davila;Int J Hematol,2016

2. Novel progresses of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma;Ding;Stem Cell Investig,2021

3. Toxicities of CD19 CAR-T cell immunotherapy;Hirayama;Am J Hematol,2019

4. Acute kidney injury and electrolyte abnormalities after chimeric antigen receptor T-cell (CAR-T) therapy for diffuse large B-cell lymphoma;Gupta;Am J Kidney Dis,2020

5. Acute kidney injury after CAR-T cell therapy: low incidence and rapid recovery;Gutgarts;Biol Blood Marrow Transplant,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute kidney injury following chimeric antigen receptor T-cell therapy: Epidemiology, mechanism and prognosis;Clinical Immunology;2024-09

2. Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention;Frontiers in Immunology;2024-08-26

3. Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia;Pediatric Nephrology;2024-03-20

4. Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies;Clinical Kidney Journal;2024-02-20

5. CAR-T Cell Therapy: Advances in Kidney-Related Diseases;Kidney Diseases;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3